Patient aggression towards receptionists working in general practice is a "serious workplace safety concern," concludes a review of the available published evidence, published in the open access ...

An internal survey, completed by 560 members of staff between December 2024 and March 2025, revealed that 74 per cent of ...

New analysis reveals approximately one in four people in England with a type of blood cancer face avoidable delays in diagnosis. The charity commissioned research examining 12,770 cases of chronic and ...

Patients with advanced cancer who also had cardiac defibrillators were more likely than those without these implants to receive aggressive end-of-life care, a team led by UT Southwestern Medical ...

Hip replacement patients who received “aggressive post-discharge care” from a patient-centered medical home care management model experienced reduced six-month mortality rates without increasing costs ...

“The results of our analysis showed that overall, patients with SCLC who survived to receive 3L treatment are a select group with exceptionally long 1L OS of 24.5 versus 14.9 months for ...

Patients With Aggressive Brain and Advanced Liver Cancers Treated with Geneos’ Personalized Immunotherapy for Cancer as Monotherapy Reach Five Years of Durable Recurrence-Free Survival Geneos ...

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests. Photo by Adobe Stock/HealthDay News An experimental ...

For most of the past 100 years, doctors typically had three ways to treat cancer: remove it surgically, destroy it with radiation, or reduce it with chemotherapy. For many patients, these approaches ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed ...

Inhibrx Biosciences said on Thursday its experimental drug helped slow the progression of a rare and aggressive bone cancer ...